Synthesis of new unsymmetrical optically active (s)-(+)-naproxen dendrimers

Preparation of new unsymmetrical optically active (s)-(+)-naproxen dendrimers containing 2-hydroxymethyl-1,4-butanediol and 2,2-bis(hydroxymethyl)-1,4-butanediol cores is described. These polyarylester dendrimers are unsymmetrical with respect to chain lengths and aid in studying controlled drug delivery based on differential enzymatic cleavage. Synthesis of a new acid dendritic wedge containing (s)-(+)-naproxen is also reported.